Trevi Historical Income Statement
| TRVI Stock | USD 3.78 0.22 6.18% |
Historical analysis of Trevi Therapeutics income statement accounts such as Total Revenue of 0.0, Other Operating Expenses of 25 M, Research Development of 18.6 M or Cost Of Revenue of 148.5 K can show how well Trevi Therapeutics performed in making a profits. Evaluating Trevi Therapeutics income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Trevi Therapeutics's future profits or losses.
Financial Statement Analysis is much more than just reviewing and examining Trevi Therapeutics latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Trevi Therapeutics is a good buy for the upcoming year.
Trevi |
About Trevi Income Statement Analysis
Trevi Therapeutics Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Trevi Therapeutics shareholders. The income statement also shows Trevi investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).
Trevi Therapeutics Income Statement Chart
Add Fundamental
Total Operating Expenses
The total costs associated with the day-to-day operations of a business, excluding the cost of goods sold but including selling, general, and administrative expenses.Most accounts from Trevi Therapeutics' income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Trevi Therapeutics current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Trevi Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real. For more detail on how to invest in Trevi Stock please use our How to Invest in Trevi Therapeutics guide.As of now, Trevi Therapeutics' Total Other Income Expense Net is increasing as compared to previous years. The Trevi Therapeutics' current Net Interest Income is estimated to increase to about 4.9 M, while Tax Provision is projected to decrease to (66.2 K).
Trevi Therapeutics income statement Correlations
Click cells to compare fundamentals
Trevi Therapeutics Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Trevi Therapeutics income statement Accounts
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Interest Income | 178K | 10K | 1.7M | 4.7M | 5.4M | 5.7M | |
| Interest Expense | 456K | 1.2M | 780K | 391K | 351.9K | 696.1K | |
| Selling General Administrative | 10.2M | 9.5M | 10.1M | 10.0M | 11.4M | 7.6M | |
| Gross Profit | (47K) | (50K) | (43K) | (123K) | (110.7K) | (105.2K) | |
| Other Operating Expenses | 32.5M | 32.5M | 29.9M | 33.9M | 39.0M | 25.0M | |
| Operating Income | (32.5M) | (32.5M) | (29.9M) | (33.9M) | (30.5M) | (32.1M) | |
| Net Income From Continuing Ops | (32.8M) | (33.9M) | (29.2M) | (26.7M) | (24.1M) | (25.3M) | |
| Ebit | (32.5M) | (32.5M) | (29.9M) | (33.9M) | (30.5M) | (32.1M) | |
| Research Development | 22.3M | 23.0M | 19.8M | 23.7M | 27.2M | 18.6M | |
| Cost Of Revenue | 47K | 50K | 43K | 123K | 141.5K | 148.5K | |
| Total Operating Expenses | 32.5M | 32.5M | 29.9M | 33.9M | 39.0M | 26.2M | |
| Income Before Tax | (32.8M) | (34.0M) | (29.2M) | (29.1M) | (26.2M) | (27.5M) | |
| Total Other Income Expense Net | (287K) | (1.5M) | 719K | 4.8M | 5.5M | 5.8M | |
| Net Income Applicable To Common Shares | (26.8M) | (32.8M) | (33.9M) | (29.2M) | (26.2M) | (27.5M) | |
| Net Income | (32.8M) | (33.9M) | (29.2M) | (29.1M) | (26.2M) | (27.5M) | |
| Net Interest Income | (278K) | (1.2M) | 577K | 4.1M | 4.7M | 4.9M | |
| Depreciation And Amortization | 47K | 50K | 43K | 123K | 141.5K | 148.5K | |
| Ebitda | (32.4M) | (32.4M) | (29.9M) | (33.8M) | (30.4M) | (31.9M) | |
| Reconciled Depreciation | 47K | 50K | 43K | 103K | 118.5K | 124.4K |
Currently Active Assets on Macroaxis
When determining whether Trevi Therapeutics offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Trevi Therapeutics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Trevi Therapeutics Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Trevi Therapeutics Stock:Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Trevi Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real. For more detail on how to invest in Trevi Stock please use our How to Invest in Trevi Therapeutics guide.You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Trevi Therapeutics. If investors know Trevi will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Trevi Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Trevi Therapeutics is measured differently than its book value, which is the value of Trevi that is recorded on the company's balance sheet. Investors also form their own opinion of Trevi Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Trevi Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Trevi Therapeutics' market value can be influenced by many factors that don't directly affect Trevi Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Trevi Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Trevi Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Trevi Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.